GSK - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
Business & Industry
- Pfizer and BioNTech to provide 500 million doses of COVID-19 vaccine to U.S. government for donation to poorest nations
- Valneva completes Phase 3 trial recruitment for its inactivated COVID-19 vaccine candidate
- Bayer to advance two first-of-its-kind cell and gene therapies for Parkinson's disease
- Pfizer and BioNTech receive first authorization in European Union for COVID-19 vaccine in adolescents
- Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19
Research & Development
- An omega-3 that's poison for tumors
- Common diabetes drug shows promise as treatment for COVID-19 lung inflammation
- CDC COVID-19 study shows mRNA vaccines reduce risk of infection by 91 percent for fully vaccinated people
- Protein identified as new therapeutic anti-viral target for COVID-19
- Monoclonal antibody prevents HIV infection in monkeys, study finds
- NIH researchers identify potential new antiviral drug for COVID-19
- How to obtain immune bovine milk to strengthen the body against COVID-19
Conferences & Events
- Scientists urge for investment now in highly potent vaccines to prevent the next pandemic
- CPhI Worldwide to return in 2021
- Reuters Events' Cell & Gene Therapy USA
- Total health: Build a better healthcare system
- Don't fall for the 'next best action' trap
- Locking down shape-shifting spike protein aids development of COVID-19 vaccine
- COVID-19 vaccine innovation could dramatically speed up worldwide production
Regulatory Affairs
- FDA grants accelerated approval for Alzheimer's drug
- FDA approves new drug treatment for chronic weight management, first since 2014
- FDA authorizes additional monoclonal antibody for treatment of COVID-19
- FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic
- FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review